The breast reconstruction market is expanding due to rising breast cancer incidence and prevalence rates as well as increased public awareness of reconstructive breast surgery. The growth can be attributed with the increase in breast cancer cases and the availability of favorable reimbursement policies. In addition, technological advancements and an increase in breast reconstruction procedures are anticipated to fuel market expansion.
According to Data Bridge Market Research, the Asia-Pacific Breast Reconstruction Market was USD 128.88 million in 2022, is expected to reach USD 266.38 million by 2030, at a CAGR of 9.5% during the forecast period 2023 to 2030
"Increasiing no. of people are being diagnosed with breast cancer boost market expansion.”
There are now more people with breast cancer worldwide. By 2020, the WHO projects that 2.3 million women will receive a breast cancer diagnosis globally. Additionally, between 2015 and 2020, 7.8 million new cases of breast cancer were diagnosed, according to a similar source. According to Cancer Research U.K., about 55,900 breast cancer cases are diagnosed yearly in the U.K. alone. According to a similar source, breast cancer is also the most prevalent type in the U.K. The demand for breast reconstruction is anticipated to increase due to the rise in breast cancer diagnoses, driving market expansion over the forecast period. Similar to the United States, one in seven women in the United Kingdom will receive a breast cancer diagnosis, according to Breast Cancer Now. The market will expand as a result of the more significant number of people who are in need.
What restraints the growth of the Asia-Pacific Breast Reconstruction Market?
" High cost of surgical expenses will limit the market growth rate."
The breast reconstruction market's growth has been restrained by high surgical costs and challenges, including adverse surgical outcomes, changes in nipple and breast sensation, scar development, and, in some cases, rupture with deflation of saline-filled implants related to breast reconstructions. As hematoma, skin necrosis, and seroma are the most frequently reported complications following ADM breast reconstruction procedures, these problems are associated with Acellular Dermal Matrices (ADMs).
Segmentation: Asia-Pacific Breast Reconstruction Market
The Asia-Pacific breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure, end user.
- On the basis of product, the breast reconstruction market is segmented into breast implants, silicone implants, saline implants, tissue expanders, acellular dermal matrix.
- On the basis of type, the breast reconstruction market is segmented into unilateral, bilateral.
- On the basis of shape, the breast reconstruction market is segmented into round implants, anatomical implants.
- On the basis of technology, the breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, transumbilical.
- On the basis of placement, the breast reconstruction market is segmented into dual-plane insertion, subglandular insertion, submuscular insertion.
- On the basis of procedure, the breast reconstruction market is segmented into immediate procedures, delayed procedures, revision procedures.
- On the basis of end user, the breast reconstruction market is segmented into hospitals, cosmetology clinics, ambulatory surgical centers, others.
Regional Insights: Japan is expected to dominate the Asia-Pacific Breast Reconstruction Market
Japan is growing at the fastest rate in the region due to rising demand for aesthetic procedures. It is growing rapidly due to the increasing adoption of aesthetic breast surgery procedures to treat breast ptosis.
To know more about the study, visit, https://www.databridgemarketresearch.com/reports/asia-pacific-breast-reconstruction-market
Recent Developments in Asia-Pacific Breast Reconstruction Market
- In 2020, The product portfolios of both companies were combined following Allergan's complete acquisition by AbbVie Inc. By combining the product portfolios of the two businesses, this acquisition helped AbbVie Inc. grow its market and demand for its product in the future, strengthening their business.
- In 2019, Premarket Approval (PMA) Application was used by Johnson & Johnson Services, Inc.'s brand Mentor to obtain FDA approval for the Memory Shape device. The company's portfolio expansion in the breast reconstruction implant market has benefited from this.
The Prominent Key Players Operating in the Asia-Pacific Breast Reconstruction Market Include:
- POLYTECH Health & Aesthetics GmbH (Germany)
- CEREPLAS (France)
- Guangzhou Wanhe Plastic Material Co., Ltd (China)
- Johnson & Johnson Private Limited (U.S.)
- GC Aesthetics (U.K.)
- Laboratories Arion (France)
- Sientra Inc. (U.S.)
- HANSBIOMED CO. LTD (South Korea)
- Sientra, Inc. (U.S.)
- Deal Implant Incorporated (U.S.)
- Integra LifeSciences (U.S.)
- PMT Corporation (U.S.)
- RTI Surgical (U.S.)
- Establishment Labs S.A. (U.S.)
- Silimed (Brazil)
Above are the key players covered in the report, to know about more and exhaustive list of Asia-Pacific breast reconstruction market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Asia-Pacific Breast Reconstruction Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, global vs regional and vendor share analysis. Please request analyst call in case of further inquiry.
